(S1 (S (NP (NN Bay11-7082)) (VP (VBZ inhibits) (NP (NN pro-IL-1beta) (NN production)) (PP (IN in) (NN response) (TO to) (NP (FW P.) (FW aeruginosa))))))
(S1 (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN NF-kappaB) (NN activity))))))) (, ,) (NP (NN Bay11-7082)) (VP (MD can) (ADVP (RB also)) (ADVP (RB directly)) (VP (VB inhibit) (NP (NP (DT the) (NN NLRP3) (NN inflammasome)) (-LRB- -LSB-) (CD 38) (-RRB- -RSB-))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB validate) (NP (NP (PRP$ its) (NN use)) (PP (IN in) (NP (DT this) (NN study))) (PP (IN as) (NP (DT an) (NN NF-kappaB) (NN inhibitor))))))) (, ,) (NP (NP (NN western) (NNS blots)) (PP (IN for) (NP (NN pro-IL-1beta)))) (VP (VBD were) (VP (VBN performed) (PP (IN alongside) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN CFTR) (NN activity))) (PP (IN by) (NP (NN CFTRinh172))))) (PP (IN in) (NN response) (TO to) (NP (NP (NN PAO1)) (PP (IN at) (NP (NP (CD 4) (NNS hours)) (PP (IN after) (NP (NP (NN stimulation)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 7a)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Bay11-7082)) (VP (VBZ prevents) (NP (NP (NN production)) (PP (IN of) (NP (NN pro-IL-1beta)))) (SBAR (IN whereas) (S (NP (NN CFTRinh172)) (VP (VBZ does) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB affect) (NP (PRP it)))))))))))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBD was) (ADVP (RB further)) (VP (VBN corroborated) (PP (IN by) (NP (DT the) (NN ability) (S (NP (NN Bay11-7082)) (VP (TO to) (VP (VB inhibit) (NP (NN IkappaBalpha) (NN degradation)) (PP (IN at) (NP (QP (CD 0.5) (, ,) (CD 1) (, ,) (CC and) (CD 1.5)) (NNS hours))) (PP (IN post) (NP (NN PAO1) (NN stimulation)))))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 7b)) (-RRB- -RRB-))))) (. .)))
